BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31159154)

  • 1. p63 at the Crossroads between Stemness and Metastasis in Breast Cancer.
    Gatti V; Bongiorno-Borbone L; Fierro C; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.
    Melino G
    Cell Death Differ; 2011 Sep; 18(9):1487-99. PubMed ID: 21760596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
    Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
    Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells.
    Nekulova M; Holcakova J; Gu X; Hrabal V; Galtsidis S; Orzol P; Liu Y; Logotheti S; Zoumpourlis V; Nylander K; Coates PJ; Vojtesek B
    BMC Cancer; 2016 Oct; 16(1):782. PubMed ID: 27724925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells stemness transcription factors expression correlates with breast cancer disease stage.
    Apostolou P; Toloudi M; Chatziioannou M; Ioannou E; Papasotiriou I
    Curr Stem Cell Res Ther; 2012 Nov; 7(6):415-9. PubMed ID: 23061814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
    J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
    Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
    Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
    Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining epithelial stemness with p63.
    Melino G; Memmi EM; Pelicci PG; Bernassola F
    Sci Signal; 2015 Jul; 8(387):re9. PubMed ID: 26221054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
    Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
    J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer.
    Wang H; Gao L; Qi M; Su P; Xiong X; Zhao J; Hu J; Han B
    Biochem Biophys Res Commun; 2021 Jan; 537():22-28. PubMed ID: 33383560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.
    Amin R; Morita-Fujimura Y; Tawarayama H; Semba K; Chiba N; Fukumoto M; Ikawa S
    Mol Oncol; 2016 Apr; 10(4):575-93. PubMed ID: 26704768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells.
    Yan X; Yu Y; Li L; Chen N; Song W; He H; Dong J; Liu X; Cui J
    Cancer Med; 2018 Aug; 7(8):3548-3560. PubMed ID: 29869379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
    Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
    Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.